Advanced search
Publication Cover
Current Medical Research and Opinion Volume 28, 2012 - Issue 4
Submit an article Journal homepage
635
Views
12
CrossRef citations to date
0
Altmetric
Diabetes: Original articles

A prospective study to optimize insulin treatment by switching to insulin glargine in type 2 diabetic patients previously uncontrolled on premixed insulin: the optimization study

Wenying YangChina–Japan Friendship Hospital BeijingChinaCorrespondence[email protected]
,
Xiaofeng LvThe Military General Hospital of Beijing BeijingChina
,
Qifu LiThe First Affiliated Hospital, Chongqing Medical University ChongqingChina
,
Weiping JiaShanghai Jiao Tong University Affiliated Sixth People’s Hospital ShanghaiChina
&
Haoming TianWest China Hospital, Sichuan University ChengduChina
Pages 533-541 | Accepted 24 Feb 2012, Published online: 27 Mar 2012

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Wenying Yang, Juan Du, Minlu Zhang, Jing Hou, Xia Zhang & Nan Cui. (2022) Predictors of HbA1c reduction and hypoglycemia in type 2 diabetes mellitus individuals switching from premixed to basal insulin: an exploratory analysis of optimization study. Current Medical Research and Opinion 38:11, pages 1807-1814.
Read now

Articles from other publishers (11)

Fatima Y. AlSlail & Yasser A. Akil. (2021) Treatment Patterns, Effectiveness, and Satisfaction Among Patients with Type 2 Diabetes Treated with Insulin in Saudi Arabia: Results of the RIMODIS Study. Diabetes Therapy 12:7, pages 1965-1978.
Crossref
Takahisa Hirose, Ching-Chu Chen, Kyu Jeung Ahn & Jacek Kiljański. (2019) Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review. Diabetes Therapy 10:3, pages 805-833.
Crossref
Linong Ji, Zhengnan Gao, Bimin Shi, Rongwen Bian, Fuzai Yin, Wuyan Pang, Hong Gao & Nan Cui. (2018) Safety and Efficacy of High Versus Standard Starting Doses of Insulin Glargine in Overweight and Obese Chinese Individuals with Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Medications (Beyond VII): Study Protocol for a Randomized Controlled Trial. Advances in Therapy 35:6, pages 864-874.
Crossref
Shi Bu, Xuelian Zhang, Haiqing Zhu, Ying Shuai, Xiaoyan Xing & Wenying Yang. (2017) Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study. Diabetes Therapy 8:4, pages 887-898.
Crossref
Ying Cao, Fang Gao, Qian Zhang, Lingling Xu, Qian Wan, Wenqi Li, Jimin Li, Ling Wang & Yaoming Xue. (2016) Efficacy and safety of coadministration of sitagliptin with insulin glargine in type 2 diabetes. Journal of Diabetes 9:5, pages 502-509.
Crossref
Bo Zhang, Jing Zhao & Wenying Yang. (2017) Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study. Diabetes/Metabolism Research and Reviews 33:3, pages e2863.
Crossref
Wenying Yang, Zhaojun Yang, Jing Zhao, Hai Lu & Tianhong Luo. (2016) Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trial. Trials 17:1.
Crossref
Marcin Czech, Elżbieta Rdzanek, Justyna Pawęska, Olga Adamowicz-Sidor, Maciej Niewada & Michał Jakubczyk. (2015) Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis. BMC Endocrine Disorders 15:1.
Crossref
Weiping Jia, Xinhua Xiao, Qiuhe Ji, Kyu-Jeung Ahn, Lee-Ming Chuang, Yuqian Bao, Can Pang, Lei Chen, Fei Gao, Yinfang Tu, Pengfei Li & Jun Yang. (2015) Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial. The Lancet Diabetes & Endocrinology 3:4, pages 254-262.
Crossref
YONG-BO WANG, SHUANG WANG, RAN BAI, JIAN-LING DU, QIAN XING, YING BA, YU YANG, XUE-YAN ZHANG, CHUN-HONG SHI & JUN-JIE YAO. (2014) Efficacy of switching from premixed insulin to insulin glargine regimen in Type 2 diabetes mellitus patients with different islet functions. Molecular Medicine Reports 10:2, pages 1096-1102.
Crossref
Masayuki Kobayashi, Shoko Tsukube, Yukio Ikeda & Yujin Shuto. (2014) Safety and Efficacy of Combination Therapy with Insulin Glargine and Oral Hypoglycaemic Agents Including DPP-4 Inhibitors in Japanese T2DM Patients: ALOHA 2 Study, a Post-Marketing Surveillance for Lantus<sup>&reg;</sup>. Journal of Diabetes Mellitus 04:04, pages 273-289.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.